Back to Agenda
Session 6 Track E: Good Publication Practice 3: Ethical and Transparent Publication Practice
Session Chair(s)
Diane Moniz Reed, PHARMD
Immuno-Oncology Early Assets, Biomarker Publications and Scientific Content, Bristol-Myers Squibb, United States
Learning Objective : - Discuss why GPP Guidelines are relevant to Medical Writers and all stakeholders involved with industry sponsored presentations and publications
- Describe the key guidelines that are considered industry best practice
- Explain the main elements of the newly-published GPP3 that are particularly important to Medical Writers
- Describe how to access the key Good Publication Practice Guidelines, including GPP3
Speaker(s)
Diane Moniz Reed, PHARMD
Immuno-Oncology Early Assets, Biomarker Publications and Scientific Content, Bristol-Myers Squibb, United States
Kim Pepitone
Scientific Director, Cactus Communications, Inc., United States
Eileen Girten, MS
Medical Writing Therapeutic Area Lead, Pfizer, United States
Christian Klem
Sr. Director, Global Scientific Publications & Communications, CV, AstraZeneca Pharmaceuticals, United States
Have an account?
